Results 221 to 230 of about 589,865 (354)

Brentuximab vedotin and radiotherapy for CD30‐positive cutaneous T‐cell lymphoma – a retrospective multicenter analysis

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives While brentuximab vedotin (BV) and radiotherapy (RTx) are established treatment options for CD30‐positive cutaneous T‐cell lymphoma (CTCL), data on their simultaneous or sequential use regarding efficacy and tolerability remain scarce.
Patrick Schummer, Caroline Glatzel, Philipp Schrüfer, Ingulf Lawrenz, Gabor Dobos, Ulrike Wehkamp, Svea Hüning, René Stranzenbach, Jan P. Nicolay, Matthias Goebeler, Marion Wobser   +10 more
wiley   +1 more source

Breast Mass as an Atypical Presentation of Non-Hodgkin Lymphoma. [PDF]

Cureus
Figueiredo F, Valido T, Chumbo C, Gomes G, Rocha M.   +4 more
europepmc   +1 more source

Recent trends of incidence and mortality of cutaneous lymphomas in Germany

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background Primary cutaneous lymphomas (PCL) are primarily composed of cutaneous T‐cell lymphomas (CTCL), followed by cutaneous B‐cell lymphomas (CBCL). This study aimed to assess the incidence and survival rates of PCL in Germany. Methods We analyzed data from the North Rhine‐Westphalia Cancer Registry (2008–2021), which covers a population of
Khodr Cheikh El Najjarine, Hiltraud Kajüter, Ina Wellmann, Andreas Stang, Chalid Assaf   +4 more
wiley   +1 more source

PO-0849: Heart structures sparing through volumetric modulated arc therapy in mediastinal Hodgkin lymphoma

, 2016
Andrea Riccardo Filippi, Mario Levis, A. Girardi, C. Fiandra, Federica Cadoni, V. Papurello, Cristina Piva, Isabella Donegani, Riccardo Ragona, Umberto Ricardi   +9 more
openalex   +1 more source

Novel bispecific antibody causes tumor regression in patients with non-Hodgkin lymphoma [PDF]

, 2008

openalex   +1 more source

Validation of prognostic scores in patients with HIV‐related diffuse large B‐cell lymphoma: The value of peripheral blood parameters—A study from the Spanish Lymphoma Group GELTAMO

British Journal of Haematology, EarlyView.
Maria Huguet, Mireia Morgades, Alfredo Rivas‐Delgado, Mariana Bastos‐Oreiro, Raúl Córdoba, Antonio Salar, Fátima de la Cruz‐Vicente, Miguel Alcoceba, Blanca Ferrer‐Lores, Ana Jiménez‐Ubieto, Antonio Gutiérrez, María Infante, Sofía Huerga, Pau Abrisqueta, David Cruz, Carlos Montalbán, Ana Muntañola, Sonia González‐de Villambrosia, Josep‐Maria Ribera, José‐Tomás Navarro   +19 more
wiley   +1 more source

A Rare Case of Non-Hodgkin Lymphoma of the Tracheobronchial Tree. [PDF]

Cureus
Jain NP, Hirani N, Khilnani AK, Oza C, Patel K.   +4 more
europepmc   +1 more source

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.

New England Journal of Medicine, 2018
J. Connors, W. Jurczak, D. Straus, S. Ansell, W. Kim, A. Gallamini, A. Younes, S. Alekseev, Á. Illés, M. Picardi, E. Lech-Maranda, Y. Oki, T. Feldman, P. Smolewski, K. Savage, N. Bartlett, J. Walewski, R. Chen, R. Ramchandren, P. Zinzani, D. Cunningham, A. Rosta, N. Josephson, E. Song, J. Sachs, R. Liu, H. Jolin, D. Huebner, J. Radford   +28 more
semanticscholar   +1 more source

Emerging Techniques in Minimally Invasive Surgery in Hematologic Malignancies

European Journal of Haematology, EarlyView.
ABSTRACT Hematologic malignancies represent the most common cancers in children. While the mainstays of treatment are chemotherapy and potentially hematopoietic stem cell transplant, minimally invasive surgery (MIS) has a role in the diagnosis and management of complications related both to disease and therapy as well as common pediatric surgical ...
Alejandro Chara, Katlyn G. McKay, Harold N. Lovvorn III, Joseph C. Fusco   +3 more
wiley   +1 more source

Hodgkin Lymphoma Classification-From Historical Concepts to Current Refinements. [PDF]

Cancers (Basel)
Carbone A, Alibrahim MN.
europepmc   +1 more source